Gadolinium deposition in nephrogenic fibrosing dermopathy
- PMID: 17109993
- DOI: 10.1016/j.jaad.2006.10.048
Gadolinium deposition in nephrogenic fibrosing dermopathy
Abstract
There is growing recognition of the association between the use of gadolinium-containing radiocontrast agents for magnetic resonance imaging and the serious dermal and systemic disease nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis (NFD/NSF). The pathogenesis of this entity remains unclear; however, our recent observations suggest a likely mechanism for the initial dermal manifestations of this gadolinium toxicity.
Comment in
-
Gadolinium is not deposited in the skin of patients with normal renal function after exposure to gadolinium-based contrast agents.J Am Acad Dermatol. 2008 Aug;59(2):356-8. doi: 10.1016/j.jaad.2008.01.025. J Am Acad Dermatol. 2008. PMID: 18638638 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
